A 4184
Referred to committee
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
- New Jersey
- House / Assembly
- Introduced Feb 19, 2026
- Session 222
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
New Jersey’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
1 action-
Introduced, Referred to Assembly Health Committee